NFE2L2 and asthma: Naringenin, 2-trifluoromethyl-2′-methoxychalone, edaravone, and RTA-408 are known to activate Nrf2 and have been reported to suppress eosinophilic airway inflammation and AHR in a mouse model of OVA-induced asthma [36,37,38,39].